NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

This strikes me as unambiguous...

Ms. Powers continued: “We believe it is now appropriate for the Company to move forward with the several stages of work that are needed to reach completion of this trial program, despite the fact that there are good arguments for allowing the data to mature even further.

I understand that there are other parts of the PR that seem less exact, but I would put that down this time to legal caution, and possibly opting not to commit to a hard and fast deadline in the event that it takes a longer time than what they might cite.

Certainly, they wouldn't want yet another SEC subpoena landing on their doorstep looking into a possible missed guidance on that. After all, they received one for the "planned publication of interim clinical trial data" - in other words, the journal, after having briefly alluded to it at ASCO 2017, then there was a sentence about it on a slide from an August presentation slide given by Dr. Bosch, and then finally, there was an 8K regarding guidance - indicating they were cancelling that UK event due to their "anticipation" of that publication stating, "While anticipating the disclosure of interim blinded data from the Company’s Phase 3 trial of DCVax®-L for Glioblastoma, the Company will not be presenting at this year’s SMi conference."

I mean really. And that merited an SEC subpoena?